Clinical Trials Browser

Phase 2/3 × Leukemia, Promyelocytic, Acute × venetoclax × Clear all

NCT06544109 2024-08-09

Ven APL

Phase 2/3 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute